Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue [NA]
A French clinical investigation evaluating Aquablation therapy (waterjet ablation) for endoscopic resection of prostate tissue in benign pro…
-
CLINICAL_TRIALS research · 2019-02-20Clinical Trial Update: Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques [NA]
A clinical trial update compares urodynamic outcomes between Aquablation and laser techniques for benign prostatic hyperplasia, but the curr…
-
CLINICAL_TRIALS research · 2019-02-06Clinical Trial Update: The Zenflow Spring System Feasibility and Safety Study [NA]
A clinical trial update for the Zenflow Spring System feasibility and safety study in benign prostatic hyperplasia has been posted. The curr…
-
FDA approval · 2019-02-05FDA Approved: TADALAFIL — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic tadalafil under an Original Application (ANDA), enabling a new generic version of tadalafil for …
-
FDA approval · 2019-02-05FDA Approved: TADALAFIL — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original application for tadalafil by Quallent Pharmaceuticals Health LLC, making the first generic tadalafil available for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-02-05FDA Approved: TADALAFIL — Original Application (Dr.Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' tadalafil as an original application (ANDA) generic product.
-
FDA approval · 2019-02-05FDA Approved: TADALAFIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for tadalafil, a generic version of the erectile dysfunction medication Cialis.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy [Phase 4]
Phase 4 trial update evaluating preemptive analgesia during cystoscopy and its effect on comfort for patients and doctors.
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory Surgery
The clinical trial evaluating patient satisfaction after laser treatment for mild prostatic hyperplasia in ambulatory surgery has been withd…
-
CLINICAL_TRIALS research · 2019-01-18Clinical Trial Update: Registry: TPLA for LUTS
A clinical trial registry entry for transperineal laser ablation (TPLA) being studied for lower urinary tract symptoms and benign prostatic …
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. [Phase 2]
Phase 2 trial evaluating different doses of UK-369,003 for lower urinary tract symptoms due to prostatic hyperplasia has completed.
-
FDA approval · 2018-12-10FDA Approved: SILODOSIN — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for silodosin from Aurobindo Pharma Limited as a generic treatment for symptoms of benign prostatic hyp…
-
FDA approval · 2018-12-07FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Alfuzosin hydrochloride from Aurobindo Pharma Limited. Alfuzosin hydrochloride is approved a…
-
FDA approval · 2018-12-07FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for alfuzosin hydrochloride from Apotex Corp., indicating an updated or expanded aspect of the a…
-
FDA approval · 2018-12-07FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for alfuzosin hydrochloride (generic) from Unichem Pharmaceuticals (USA), Inc., to support changes t…
-
FDA approval · 2018-12-03FDA Approved: SILODOSIN — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for silodosin, the generic form of the drug used to treat benign prostatic hyperplasia…
-
FDA approval · 2018-12-03FDA Approved: SILODOSIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA for silodosin as a generic product from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2018-12-03FDA Approved: SILODOSIN — Original Application (Ajanta Pharma USA Inc.)
FDA approves the original Abbreviated New Drug Application for generic silodosin from Ajanta Pharma USA Inc. for the treatment of symptoms o…
-
FDA approval · 2018-12-03FDA Approved: SILODOSIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic silodosin for the treatment of lower urinary tract symptoms due to benign prostatic …
-
FDA approval · 2018-12-03FDA Approved: SILODOSIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original application for silodosin (generic) for the treatment of benign prostatic hyperplasia.
-
FDA approval · 2018-11-14FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for alfuzosin hydrochloride by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams [Phase 2]
Phase 2 clinical trial investigating prostatic artery embolization for benign prostatic hyperplasia in men with prostates >90 grams; study t…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) [Phase 2, Phase 3]
Phase 2/3 study update on fedovapagon for nocturia in men with benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression [Phase 3]
Phase 3 clinical trial assessing safety and efficacy of Afalaza for symptoms and progression risk in benign prostatic hyperplasia; study com…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Medical Therapy of Prostatic Symptoms [Phase 3]
Phase 3 clinical trial update on medical therapy for prostatic symptoms (benign prostatic hyperplasia).